Adicet Bio Inc ACET

$4.28 -0.21 (-4.68%)

Valuation

Market cap
42,033,000
Revenue TTM
$0
Net income TTM
$-116,800,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
157,000
Avg volume
218,044
Day's range
$4.21 – $4.72
Shares out
9,361,000
Stochastic %K
4%
Beta
1.62
Analysts
Strong Sell
Price target
$34.83

Price

Company profile

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edite...

Show more

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
650 503 9095
Website
https://www.adicetbio.com
Address
131 Dartmouth Street, 3rd Floor, Boston, United States

Latest news

Stocktwits

AlexRo777 Oct 16, 4:33 PM
$ACET Health Care Select Sector SPDR Fund $XLV notched an all-time high recently, with AbbVie, Gilead, Thermo Fisher all tagging record levels too, and Eli Lilly trading super close to its own top… this is getting delisted soon doesn’t make sense making all time lows so many times when the health cares sector is at all time high..
0 replies
AlexRo777 Oct 16, 4:22 PM
$ACET for stocktwist 52 weeks low is 4.8$ but they need to update it, this is doing new all time lows every other hour… ridiculous
0 replies
AlexRo777 Oct 16, 4:06 PM
$ACET what it’s connected to AI stocks again, shambles what a company, why no one is buying, I thought very good data should expect a bit of interest, no money. Low volume dumping high volume same thing
0 replies
AlexRo777 Oct 16, 2:15 PM
$ACET I hate biotech, i bought when they released the positive data 2 weeks ago down over 50%
0 replies
AlexRo777 Oct 14, 8:55 PM
$ACET when they released the data 2 weeks ago, they were over 10 dollar per share, now sitting at 4 dollars and not even a bounce at all… how they lost more than half of the value in 2 weeks with 47 million market cap. They don’t have any cash or what?!
1 replies
AlexRo777 Oct 14, 8:44 PM
$ACET -48.6% down in a month with a positive news in the same month, is this following Both Caribou Biosciences and Cellectis recently abandoned their internal allogeneic CAR-T cell therapy programs and pivoted away from the space due to tough capital-raising environments, high manufacturing/development costs…
0 replies
DCZ Oct 10, 12:27 PM
$ACET anyone else buying this the last few days? I’ve been buying like crazy, which is either incredibly stupid or incredibly smart. Time will tell.
2 replies
AlexRo777 Oct 6, 11:31 PM
$ACET all car-t are struggling look at $CRBU it’s done now with discontinuation of its internal CAR-T programs, even other companies are scrapping some of their programs or pivoting like $CLLS , even $CAPR it started a bearish trend.
2 replies